Due to glucose deficiency in the tumor microenvironment and competition for glucose by tumor cells, the glycolytic capacity of CD8+ T cells decreases, resulting in reduced cytokine production and antitumor ability [117]. This evidence concerns the gene CD8A and neoplasm.